Retifanlimab

Tax included
Retifanlimab is an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody (mAb). Retifanlimab can be used for the research of gastroesophageal adenocarcinoma (GEA).
MedChemExpress 
HY-P99941

Data sheet

Size
Multiple sizes
Reactivity
PD-1/PD-L1
CAS
2079108-44-2